Cargando…
Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
Anti HCV vaccine is not currently available and the present antiviral therapies fail to cure approximately half of the treated HCV patients. This study was designed to assess the immunogenic properties of genetically conserved peptides derived from the C-terminal region of HVR-1 and test their neutr...
Autores principales: | El Abd, Yasmine S, Tabll, Ashraf A, El Din, Noha G Bader, Hosny, Alaa El-Dien S, Moustafa, Rehab I, El-Shenawy, Reem, Atef, Khaled, El-Awady, Mostafa K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179750/ https://www.ncbi.nlm.nih.gov/pubmed/21819575 http://dx.doi.org/10.1186/1743-422X-8-391 |
Ejemplares similares
-
Circulating viral core and E1 antigen levels as supplemental markers for HCV Chronic hepatitis
por: El Awady, Mostafa K, et al.
Publicado: (2006) -
A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice
por: Dawood, Reham M., et al.
Publicado: (2019) -
Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goats
por: El-Awady, Mostafa K, et al.
Publicado: (2009) -
Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
por: Tabll, Ashraf, et al.
Publicado: (2011) -
A Study of CC-Chemokine Receptor 5 (CCR5) Polymorphism on the Outcome of HCV Therapy in Egyptian Patients
por: Omran, Moataza H, et al.
Publicado: (2013)